Processing your payment...
Please do not close your browser.

Hyperimmune Globulins Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions, and By Key Players: Grifols (BME: GRF), Biotest (ETR: BIO), ADMA Biologics (NASDAQ: ADMA)

08 Jun, 2022 | 140 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Registering a CAGR of 7.5% over the forecast period, the market value of Hyperimmune Globulins is expected to reach US$ 2290.7 million in the year 2027.



Hyperimmune Globulins Market Overview



Hyperimmune globulins are immune globulin solutions that are high in antibodies and provide protection against specific diseases by providing passive immunity. Passive immunity is achieved through the administration of purified antibodies that provide immediate and short-term protection against the disease.



The global increase in deadly disease outbreaks is driving the market growth. Hyperimmune globulins are typically used to treat active infections in immunocompromised individuals. Hyperimmune globulins (HIGs) are similar to IVIGs (intravenous immunoglobulins), but they are made from plasma from donors who have high antibody titers against a specific antigen or organism. These donors were either naturally infected or previously exposed to the disease, or they were artificially immunized.



Human hyperimmune globulins are desirable, but donor screening protocols are expensive, and the risk of transmitting unidentified pathogens prevents the widespread use of human immune plasma products. In some cases, these solutions may have serious side effects, which may lead to industry growth.



The report aspects discussed the profile of the top manufacturers of the global Hyperimmune Globulins market. These aspects include the financial status of major companies, trending advancements, and the entire market scenario. Growth of the report has examined Hyperimmune Globulins Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.



Who are the Major Players in the Hyperimmune Globulins Market?



The global Hyperimmune Globulins include the identification and analysis of the various market participants competing in the global market. Prominent competitors include CSL Behring, Grifols (BME: GRF), Biotest (ETR: BIO), Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics (NASDAQ: ADMA) and others.



Industry News and Updates:



Grifols Announces Formal Collaboration with US Government to Develop the First COVID-19-Specific Treatment



March 25, 2020 – Grifols has announced a formal collaboration with the United States Biomedical Advanced Research Development Authority (BARDA), the Food and Drug Administration (FDA), and other Federal public health agencies to collect plasma from convalescent COVID-19 patients, process this plasma into a hyperimmune globulin, and support the necessary preclinical and clinical studies to determine whether anti-SARS-CoV-2 hyperimmune globulin therapy can be successful.





What are the major Applications, Types, and Regions for the Hyperimmune Globulins Market?



The market is segmented based on the type, applications, companies, and regions.



By Type, it is segmented into




  • Hepatitis B Immunoglobulins

  • Rabies Immunoglobulins

  • Tetanus Immunoglobulins

  • Rho(D) Immunoglobulins

  • Other



By Application, it is segmented into




  • Government Institutions

  • Private Sector

  • Other



Hyperimmune Globulins Market Regional Analysis



During the forecast period, Europe is expected to claim a massive revenue share, retaining its dominant position in the global hyperimmune globulin market. It is important to note that, while a variety of factors contribute to this coveted position, some of the most prominent ones are the rapidly aging population and the presence of advanced healthcare infrastructure.




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The Hyperimmune Globulins Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type, and segment. It focuses extensively on revealing a detailed regional analysis. The Global Hyperimmune Globulins Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Hyperimmune Globulins Market report scope?



Scope of the Report covers Hyperimmune Globulins Market with a detailed analysis of the overall scenario for the market. It also highlights the business participants’ environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background, and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Hyperimmune Globulins Market analysis report as it has vital details to provide about regional markets and expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how the worldwide market is working through efficient information graphics.



























































Report Attributes



Report Details



Report Title



Hyperimmune Globulins Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions, and By Key Players: Grifols (BME: GRF), Biotest (ETR: BIO), ADMA Biologics (NASDAQ: ADMA)



Forecast Period 2022 to 2027 CAGR



CAGR of 7.5% over the forecast period (2022-2027)



By Type




  • Hepatitis B Immunoglobulins

  • Rabies Immunoglobulins

  • Tetanus Immunoglobulins

  • Rho(D) Immunoglobulins

  • Other



By Application




  • Government Institutions

  • Private Sector

  • Other



By Companies



CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



2022



Historical Year



2017 to 2021



Forecast Year



2022 to 2027



Number of Pages



140



Customization Available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Key Takeaways from this Hyperimmune Globulins Report




  • Evaluate Hyperimmune Globulins market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at the country level - for product types, end-use applications, and different industries verticals.

  • Understand the different dynamics influencing the market - growth driving factors, specific challenges, and hidden opportunities.

  • Get in-depth insights on your competitor’s performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis, and more.

  • Analyze the sales and distribution channels across geographies to enhance top-line revenues.

  • Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies to your processes.

  • Get a quick outlook on the Hyperimmune Globulins market entropy – M&As, deals, partnerships, and product launches of all key players for the past 5 years.

  • Evaluate the import-export statistics, supply-demand, and competitive landscape for more than the top 20 countries globally for the market.



Frequently Asked Questions



What is the study period of this market?





The Hyperimmune Globulins Market is studied from 2017 - 2027.



What is the growth rate of the Hyperimmune Globulins Market?





The Hyperimmune Globulins Market is growing at a CAGR of 7.5% over the next 5 years.



Who are the key players in Hyperimmune Globulins Market?



CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics



What regions does this Hyperimmune Globulins Market report cover?





North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)



What are the significant types of Hyperimmune Globulins Market?



Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins, Rho(D) Immunoglobulins, Other



What are the major end-use applications of Hyperimmune Globulins Market?



Government Institutions, Private Sector, Other

 



All our reports are custom made to your company’s needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.


  1. INTRODUCTION

    1. MARKET DEFINITION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMELINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL HYPERIMMUNE GLOBULINS MARKET BY APPLICATION

    3. GLOBAL HYPERIMMUNE GLOBULINS MARKET BY TYPES



  4. MARKET DYNAMICS

    1. DRIVERS

    2. INCREASING DEMAND FOR HYPERIMMUNE GLOBULINS RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGULATIONS

      2. HIGH COST OF RAW MATERIAL



    3. OPPORTUNITIES

      1. HYPERIMMUNE GLOBULINS GROWTH

      2. APPLICATION OF HYPERIMMUNE GLOBULINS



    4. IMPACT OF COVID 19



  5. GLOBAL HYPERIMMUNE GLOBULINS MARKET, BY TYPES

    1. INTRODUCTION

    2. HEPATITIS B IMMUNOGLOBULINS

    3. RABIES IMMUNOGLOBULINS

    4. TETANUS IMMUNOGLOBULINS

    5. RHO(D) IMMUNOGLOBULINS

    6. OTHER



  6. GLOBAL HYPERIMMUNE GLOBULINS MARKET, BY APPLICATION

    1. INTRODUCTION

    2. GOVERNMENT INSTITUTIONS

    3. PRIVATE SECTOR

    4. OTHER



  7. GLOBAL HYPERIMMUNE GLOBULINS MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASIAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. CSL BEHRING

      2. GRIFOLS

      3. BIOTEST

      4. KEDRION

      5. CBPO

      6. EMERGENT (CANGENE)

      7. KAMADA

      8. CNBG

      9. HUALAN BIO

      10. SHANGHAI RAAS

      11. SICHUAN YUANDA SHUYANG

      12. ADMA BIOLOGICS





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 9
  • 3M